This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology
npj Precision Oncology Open Access 18 March 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Forbes, S. A. et al. Nucleic Acids Res. 45 (D1), D777–D783 (2017).
Berman, H. M. et al. Curr. Opin. Struct. Biol. 40, 17–22 (2016).
Velankar, S. et al. Nucleic Acids Res. 41, D483–D489 (2013).
Futreal, P. A. et al. Nat. Rev. Cancer 4, 177–183 (2004).
Rose, A. S. & Hildebrand, P. W. Nucleic Acids Res. 43 (W1), W576–W579 (2015).
UniProt Consortium. Nucleic Acids Res. 45, D158–D169 (2017).
Le Guilloux, V., Schmidtke, P. & Tuffery, P. BMC Bioinformatics 10, 168 (2009).
Gilmer, T. M. et al. Cancer Res. 68, 571–579 (2008).
Gazdar, A. F. Oncogene 28 (Suppl. 1), S24–S31 (2009).
Acknowledgements
We thank colleagues at the Wellcome Sanger Institute and Astex Pharmaceuticals for helpful comments. This work was funded by a postdoctoral fellowship awarded to H.C.J. under the Sustaining Innovation Postdoctoral Training Program at Astex Pharmaceuticals (H.C.J., H.K.S., M.L.V., S.A.F.). This work was supported by a Wellcome Trust grant (206194) (H.C.J., S.A.F.).
Author information
Authors and Affiliations
Contributions
H.C.J. contributed experimental design, performed the experiments, analyzed the data and wrote the manuscript. H.K.S., M.L.V. and S.A.F. contributed joint supervision of research, conception and design of the experiments, and writing of the manuscript.
Corresponding author
Ethics declarations
Competing interests
COSMIC-3D uses data and systems infrastructure from the COSMIC database group, which is partly funded from Wellcome Trust charitable funds together with sales of licenses to for-profit enterprises. H.K.S. and M.L.V. are employed by Astex Pharmaceuticals.
Supplementary information
Rights and permissions
About this article
Cite this article
Jubb, H.C., Saini, H.K., Verdonk, M.L. et al. COSMIC-3D provides structural perspectives on cancer genetics for drug discovery. Nat Genet 50, 1200–1202 (2018). https://doi.org/10.1038/s41588-018-0214-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0214-9
This article is cited by
-
Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology
npj Precision Oncology (2021)